MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23
11 August 2023 - 6:00AM
MDxHealth to Present Q2 and Half Year 2023 Financial Results and
Corporate Update on August 23
NEWS RELEASE10
AUGUST
2023,
4PM ET / 22:00
CET
MDxHealth to Present Q2
and Half Year
2023 Financial
Results and Corporate Update on
August 23
Company to Host Conference Call
with Live Q&A, August
23, 2023
at
4:30pm
ET/
22:30
CET
IRVINE, CA, and HERSTAL,
BELGIUM – August 10, 2023 – MDxHealth SA (NASDAQ/Euronext:
MDXH), a commercial-stage precision diagnostics company, today
announced it will release its financial results for the second
quarter and half year ended June 30, 2023, after market close on
Wednesday, August 23, 2023.
|
Title: |
MDxHealth Presents Half Year 2023 Financial Results and Recent
Corporate Update Conference Call and Webcast |
|
Speakers: |
Michael K. McGarrity, Chief Executive OfficerRon Kalfus, Chief
Financial Officer |
|
Date: |
August 23, 2023 |
|
Time: |
4:30pm ET/ 22:30 CET |
|
Conference Call Dial-in
Details: |
United States: 1-877-407-9716Belgium: 0800 73904The Netherlands:
0800 023 4340United Kingdom: 0800 756 3429 |
|
Conference ID: |
13740600 |
|
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1628877&tp_key=6fd554d31e |
The webcast should be accessed 15 minutes prior to the
conference call start time. A replay of the webcast will be
available following the conclusion of the live call and will be
accessible on the Company’s website.
About MDxHealthmdxhealth is a commercial-stage
precision diagnostics company that provides actionable molecular
information to personalize patient diagnosis and treatment. The
Company’s tests are based on proprietary genomic, epigenetic
(methylation) and other molecular technologies and assist
physicians with the diagnosis and prognosis of urologic cancers and
other urologic diseases. The Company’s U.S. headquarters and
laboratory operations are in Irvine, California, with additional
laboratory operations in Plano, Texas. European headquarters are in
Herstal, Belgium, with laboratory operations in Nijmegen, The
Netherlands. For more information,
visit mdxhealth.com and follow us on social media
at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
|
MDxHealth info@mdxhealth.com |
|
| LifeSci
Advisors (IR & PR)US: +1 949 271
9223ir@mdxhealth.com |
|
NOTE: The mdxhealth logo,
mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate
Score, GPS and Monitor mdx are trademarks or registered trademarks
of MDxHealth SA. All other trademarks and service marks are the
property of their respective owners.
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From Nov 2024 to Dec 2024
Mdxhealth (LSE:0O8G)
Historical Stock Chart
From Dec 2023 to Dec 2024
